Multiple Myeloma Management vs Multiple Myeloma [MM] Uso & Estadísticas

Bispecific antibodies are a novel mechanism in the management in the relapsed/refractory multiple myeloma. Recognizing the mechanism of these agents as well as preliminary efficacy data is important in considering clinical trials and implementing approved bispecific antibodies in the management of multiple myeloma.
  • App Store de Apple
  • Gratis
  • Medicina

Clasificación de tiendas

- -

@Point of Care™ With Cognitive AI is a clinical decision-making mobile platform. Multiple Myeloma @Point of Care™ provides a streamlined clinical decision support tool for clinicians to obtain content when it is needed—enabling better decisions, better outcomes, and better care. With Cognitive AI, clinicians use @Point of Care™ to easily access curated, evidence-based, and disease-specific medical content. Clinicians navigate content by asking voice-enabled natural language questions. With Cognitive AI, confidence-rated answers to efficiently incorporate best treatment options happen more quickly and decisions are made faster to improve patient outcomes at the point of care. Multiple Myeloma @Point of Care™ is designed to: • Support discovery and practice change • Provide relevant, evidence-based disease-specific medical content • Improve patient outcomes at the point of care Features: • Continually updated Multiple Myeloma content • Topics in diagnosis, treatment, and care management developed with expert physician authors • Case studies, videos, and interviews • Access to actionable patient-recorded data • Detailed reference list with access to original sources • Continuing medical education credit (CME/CE) • Surveys and peer polling • Patient education resources to share with patients
  • App Store de Apple
  • Gratis
  • Medicina

Clasificación de tiendas

- -

Multiple Myeloma Management frente a Multiple Myeloma [MM]: comparación de la clasificación

Comparar la tendencia de clasificación de Multiple Myeloma Management en los últimos 28 días con Multiple Myeloma [MM]

Rank

No hay datos disponibles

Comparación de las clasificaciones Multiple Myeloma Management frente a Multiple Myeloma [MM] por países

Comparar la tendencia de clasificación de Multiple Myeloma Management en los últimos 28 días con Multiple Myeloma [MM]

No hay datos para mostrar

Compara con cualquier sitio gracias a nuestra prueba gratuita

Empieza ya
Multiple Myeloma Management VS.
Multiple Myeloma [MM]

19iciembre d, 2024